• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eli Lilly (NY: LLY )

    905.59 -36.01 (-3.82%)
    Official Closing Price Updated: 7:00 PM EDT, Jul 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,200,657
    Open 910.01
    Bid (Size) 906.00 (1)
    Ask (Size) 907.43 (2)
    Prev. Close 941.60
    Today's Range 902.64 - 925.00
    52wk Range 445.04 - 966.10
    Shares Outstanding N/A
    Dividend Yield 0.50%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
    These three wild-card stocks will spice up your portfolio in ways boring diversification never could, so read on. 
    Via InvestorPlace
    Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
    Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock. 
    Via The Motley Fool

    Performance

    YTD
    +52.92%
    +52.92%
    1 Month
    +2.33%
    +2.33%
    3 Month
    +20.62%
    +20.62%
    6 Month
    +43.99%
    +43.99%
    1 Year
    +100.71%
    +100.71%

    More News

    Read More
    Pfizer And Roche Advance On Their Weight Loss Drug Journeys
    Via Benzinga
    Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
    Via Benzinga
    Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
    Via Benzinga
    Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
    Via Benzinga
    3 Unstoppable Stocks That You Can Buy and Hold for Years
    Via The Motley Fool
    Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
    Via Investor's Business Daily
    Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
    Via Benzinga
    3 Biotech Stocks to Buy in Case of Another Pandemic
    Via InvestorPlace
    How Should a Beginner Invest in Stocks? Try This Index Fund.
    Via The Motley Fool
    Topics Retirement
    Exposures Pension
    This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
    Via Benzinga
    7 Top-Quality Stocks to Buy Now: July 2024
    Via InvestorPlace
    Americans Are Flying; Airline Stocks Are Not
    Via The Motley Fool
    2 Unstoppable Growth Stocks to Buy and Hold for the Next Decade
    Via The Motley Fool
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    Via MarketBeat
    7 Billion-Dollar Stocks That Deserve a Spot in Your Portfolio
    Via InvestorPlace
    Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
    Via The Motley Fool
    3 Stocks for Patient Investors Looking to Build Generational Wealth
    Via InvestorPlace
    2 High-Flying Growth Stocks You Can Buy Right Now Before They Surge Even Higher
    Via The Motley Fool
    2 Incredibly Cheap Growth Stocks to Buy Now
    Via The Motley Fool
    Is Eli Lilly a Good Dividend Stock to Buy Now?
    Via The Motley Fool
    This 1 Piece of Bad News for Novo Nordisk Is Good News for Eli Lilly Stock
    Via The Motley Fool
    The 7 Most Important Stocks to Watch as Q2 Earnings Season Kicks Off
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.